7RQ Stock Overview
Neighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Neighbourly Pharmacy Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$12.30 |
| 52 Week High | CA$13.30 |
| 52 Week Low | CA$8.30 |
| Beta | 0.29 |
| 1 Month Change | -1.60% |
| 3 Month Change | 9.82% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -6.48% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7RQ | DE Consumer Retailing | DE Market | |
|---|---|---|---|
| 7D | 0% | 0.8% | 0.7% |
| 1Y | n/a | -12.3% | 8.4% |
Return vs Industry: Insufficient data to determine how 7RQ performed against the German Consumer Retailing industry.
Return vs Market: Insufficient data to determine how 7RQ performed against the German Market.
Price Volatility
| 7RQ volatility | |
|---|---|
| 7RQ Average Weekly Movement | 4.9% |
| Consumer Retailing Industry Average Movement | 6.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 12.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 7RQ has not had significant price volatility in the past 3 months.
Volatility Over Time: 7RQ's weekly volatility has decreased from 11% to 5% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 3,648 | Skip Bourdo | neighbourlypharmacy.ca |
Neighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada. The company sells prescription medication, confections and food, over the counter drugs, and health and beauty aids. It operates pharmacies under the various banners, such as IDA/Guardian, Pharmachoice, Pharmasave, Remedy’s RX, and Drug Trading.
Neighbourly Pharmacy Inc. Fundamentals Summary
| 7RQ fundamental statistics | |
|---|---|
| Market cap | €569.35m |
| Earnings (TTM) | -€22.20m |
| Revenue (TTM) | €593.81m |
1.0x
P/S Ratio-25.6x
P/E RatioIs 7RQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7RQ income statement (TTM) | |
|---|---|
| Revenue | CA$874.61m |
| Cost of Revenue | CA$527.56m |
| Gross Profit | CA$347.05m |
| Other Expenses | CA$379.76m |
| Earnings | -CA$32.70m |
Last Reported Earnings
Dec 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.72 |
| Gross Margin | 39.68% |
| Net Profit Margin | -3.74% |
| Debt/Equity Ratio | 44.5% |
How did 7RQ perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/03/21 06:29 |
| End of Day Share Price | 2024/03/20 00:00 |
| Earnings | 2023/12/30 |
| Annual Earnings | 2023/03/25 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Neighbourly Pharmacy Inc. is covered by 10 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Clarence Powell | BMO Capital Markets Equity Research |
| Kyle McPhee | Cormark Securities Inc. |
| Christopher Li | Desjardins Securities Inc. |